iCellate is a medical technology company. It develops products in the areas of cancer diagnosis and individual cancer treatment. iCellate’s genetic cancer evaluation, using circulating tumor cells (CTC) or circulating tumor DNA (ctDNA), provides detailed genetic tumor information which may reveal new targeted treatment options.